Clinical Trial

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-09; most recent amendment 2025-12-09.
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT07014618
Lead Sponsor University of Oklahoma
Collaborators: Gilead Sciences, Radiation Therapy Oncology Group, Susan G. Komen Breast Cancer Foundation
Conditions Breast Cancer, Prostate Cancer
Enrollment 420 participants
Start Date 2025-10-16
Primary Completion 2029-10 (estimated)
Study Completion 2030-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-17